World Malaria Day 2026: HRP2-Based Detection in Falciparum Malaria Testing
World Malaria Day is a reminder that progress against malaria depends not only on treatment access and prevention strategies, but also on the quality of diagnostic decisions made at the point of care and in the laboratory. In 2026, the World Health Organization is marking the day under the theme “Driven to End Malaria: Now […]
Medical Lab Professionals Week: The Expertise Behind Reliable HbA1c Testing
Medical Lab Professionals Week is a timely opportunity to recognize the expertise behind every actionable diagnostic result. While clinicians often see the final number, the reliability, timing, and clinical usefulness of that result depend on laboratory teams who manage pre-analytical quality, analytical precision, workflow discipline, and instrument performance every day. In diabetes management, this role […]
Mycoplasma genitalium: The STI Standard Panels Routinely Miss
Mycoplasma genitalium (MG) is an increasingly recognized sexually transmitted infection, yet it remains virtually absent from standard STI diagnostic panels. During STI Awareness Week, this gap in testing coverage demands urgent attention from laboratory professionals, healthcare providers, and public health systems. While Chlamydia trachomatis and Neisseria gonorrhoeae dominate screening protocols, MGresponsible for persistent urethritis, cervicitis, […]
The Return of Whooping Cough: Understanding the Global Pertussis Resurgence
Pertussis, commonly known as whooping cough, is re-emerging globally, with reported cases increasing across multiple regions in 2024–2026. Countries including Australia, the United States, and several regions in Latin America have reported a notable rise in incidence, prompting renewed attention from clinicians and public health systems. This resurgence reflects a broader shift in respiratory disease […]
Spring Allergy Season and Total IgE Testing: How Rapid Quantitative Measurement Guides Allergy Assessment in Primary Care
Spring brings renewal but also triggers allergic disease in millions globally. Allergic rhinitis, allergic asthma, and atopic dermatitis peak during pollen season, affecting primary care systems and patient quality of life. A blood test measuring quantitative total immunoglobulin E (total IgE) provides biomarker information about atopic disease and may assist in determining eligibility for targeted […]
β-HCG Testing and Early Pregnancy Confirmation: The Clinical Case for Quantitative Point-of-Care hCG Measurement
Qualitative pregnancy tests answer one question: yes or no. In early pregnancy, that answer is often insufficient. Clinicians managing first-trimester uncertainty, suspected ectopic pregnancy, or threatened miscarriage require quantitative measurement of human chorionic gonadotropin (β-hCG) to support clinical decision-making. Point-of-care quantitative hCG testing, completed within minutes, enables faster triage and more informed management when interpreted […]
TB in the Post-COVID Era: Why Diagnostic Gaps Are Widening and How Point-of-Care Molecular Testing Can Help
On World TB Day 2026, marked on March 24 each year, the global health community faces a sobering reality: tuberculosis remains the world’s deadliest infectious disease from a single pathogen, and the hard-won diagnostic progress of the 2010s has been sharply reversed by the COVID-19 pandemic. According to the WHO Global Tuberculosis Report 2024, an […]
Patient Safety and Diagnostic Accuracy: How Point-of-Care Testing Is Reducing Preventable Clinical Errors
Diagnostic errors are among the most prevalent and consequential threats to patient safety in modern healthcare, affecting an estimated 12 million patients annually in the United States alone, with approximately 40,000 to 80,000 deaths attributed to diagnostic failure each year. Unlike medication errors or surgical complications, diagnostic inaccuracies are frequently invisible: a missed cancer biomarker, […]
PSA Testing and Prostate Cancer: How Total PSA and Free PSA Ratio Improve Diagnostic Accuracy
Prostate cancer is the second most commonly diagnosed cancer in men worldwide, with approximately 1.4 million new cases and over 375,000 deaths reported annually – making it the fifth leading cause of cancer mortality in men globally. Prostate-specific antigen (PSA) testing remains the most widely used serological tool for prostate cancer detection, yet its value […]
Kidney Disease Early Detection with Cystatin C and Microalbumin
Chronic kidney disease (CKD) affects an estimated 850 million people worldwide and is projected to become one of the leading causes of years of life lost globally by 2040, yet many patients with early-stage CKD remain undiagnosed until kidney damage has already progressed. Two biomarkers, Cystatin C and urine microalbumin, have emerged as important tools […]
